Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The NHS England Jewish BRCA Testing Programme: overview after first year of implementation (2023-2024).

Journal of medical genetics - 27 Jan 2025

Torr Bethany, Bell Nicola, McCarthy Ruth, Hamill Monica, Nolan Joshua, Muralidharan Sudeekshna, Andrews Charlotte, Valganon-Petrizan Mikel, Clinch Yasmin, MacMahon Suzanne, Morilla Alison, George Angela, Ryves Paul, Dasani Pooja, Adegoroye Moses, Schlecht Helene, Burghel George J, Ornadel Wendy, Gordon Nicole, Steele Lisa, Lukic Susana, Watts Emily, Evans D Gareth, Manchanda Ranjit, Turnbull Clare

Abstract excerpt

BACKGROUND: The NHS Jewish BRCA Testing Programme is offering germline BRCA1 and BRCA2 genetic testing to people with ≥1 Jewish grandparent. Who have an increased likelihood of having an Ashkenazi Jewish (AJ) founder germline pathogenic variant (gPV) compared with the general population.Testing is offered via a self-referral, home-based saliva sampling pathway, supported by a genetic counsellor telephone...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to BRCA2 Protein

Share to Breast Neoplasms

Share to England

Share to Genetic Counseling

Share to Germ-Line Mutation

Share to Ovarian Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 39715636
DOI: 10.1136/jmg-2024-110390
PMCID: PMC11877082

Genes

NHS
BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 22 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The NHS England Jewish BRCA Testing Programme: overview after first year of implementation (2023-2024).PMID 39715636Read ↗

Targeted BRCA1/2 population screening among Ashkenazi Jewish individuals using a web-enabled medical model: An observational cohort study.Semantic proximity Read ↗

BRCA awareness and testing experience in the UK Jewish population: a qualitative study.Semantic proximity Read ↗

Population-based BRCA1/2 testing programmes are highly acceptable in the Jewish community: results of the JeneScreen Study.Semantic proximity Read ↗

Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women.Semantic proximity Read ↗

Identifying Ashkenazi Jewish <i>BRCA1/2</i> founder variants in individuals who do not self-report Jewish ancestrySemantic proximity Read ↗

Identifying Ashkenazi Jewish BRCA1/2 founder variants in individuals who do not self-report Jewish ancestry.Semantic proximity Read ↗

A comparison of the detection of BRCA mutation carriers through the provision of Jewish population-based genetic testing compared with clinic-based genetic testingSemantic proximity Read ↗

Building the What Comes Next Cohort for BRCA1 and BRCA2 testing: a descriptive analysis.Semantic proximity Read ↗

Population-based screening of Uruguayan Ashkenazi Jews for recurrent BRCA1 and BRCA2 pathogenic sequence variants.Semantic proximity Read ↗

Attitude towards and factors affecting uptake of population‐based BRCA testing in the Ashkenazi Jewish population: a cohort studySemantic proximity Read ↗

Population screening for BRCA1/BRCA2 founder mutations in Ashkenazi Jews: proactive recruitment compared with self-referral.Semantic proximity Read ↗

Population-Based BRCA1/2 Testing in Ashkenazi Jews: Ready for Prime Time.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.